BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37888127)

  • 1. The Benefits of a Comprehensive Cardiac Rehabilitation Program for Patients with Acute Coronary Syndrome: A Follow-Up Study.
    Craciun LM; Buleu F; Pah AM; Badalica-Petrescu M; Bodea O; Man DE; Cosor OC; Iurciuc S; Dragan S; Rada M
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ICAROS (Italian survey on CardiAc RehabilitatiOn and Secondary prevention after cardiac revascularization): temporary report of the first prospective, longitudinal registry of the cardiac rehabilitation network GICR/IACPR].
    Griffo R; Temporelli PL; Fattirolli F; Ambrosetti M; Tramarin R; Vestri AR; De Feo S; Tavazzi L;
    Monaldi Arch Chest Dis; 2012 Jun; 78(2):73-8. PubMed ID: 23167148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ambulatory cardiac rehabilitation in Trieste: protocols of intervention, activities and outcomes].
    Doimo S; Maras P; Barbati G; Fabris E; Della Mattia A; Salame K; Gatti G; Sinagra G
    G Ital Cardiol (Rome); 2017 Dec; 18(12):862-870. PubMed ID: 29189830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
    Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
    BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year prognosis and cardiovascular disease prevention after acute coronary syndrome; the role of cardiac rehabilitation: a French nationwide study.
    Blacher J; Olié V; Gabet A; Cinaud A; Tuppin P; Iliou MC; Grave C
    Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38832727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk in men with ischaemic heart disease and their participation in ambulatory comprehensive cardiac rehabilitation.
    Gołuchowska A; Rębowska E; Drygas W; Jegier A
    Kardiol Pol; 2015; 73(8):656-63. PubMed ID: 25761789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Strong Hearts program after a major cardiovascular event in patients with cardiovascular disease.
    Murphy BE; Card PD; Ramirez-Kelly L; Xaysuda AM; Heidel RE
    J Osteopath Med; 2023 Jun; 123(6):279-285. PubMed ID: 36958944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.
    Gitt A; Jannowitz C; Karoff M; Karmann B; Horack M; Völler H
    Vasc Health Risk Manag; 2012; 8():265-74. PubMed ID: 22566748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice.
    Świątkiewicz I; Di Somma S; De Fazio L; Mazzilli V; Taub PR
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outpatient cardiac rehabilitation in coronary artery disease: impact on cardiovascular outcomes].
    Mandorla S; Regni O; Giovagnoli E; Cossignani M
    G Ital Cardiol (Rome); 2021 Jul; 22(7):570-578. PubMed ID: 34175913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inpatient rehabilitation improves implementation of therapeutic guidelines for secondary prevention in patients with coronary heart disease].
    Baessler A; Fischer M; Hengstenberg C; Holmer S; Hubauer U; Huf V; Mell S; Klein G; Riegger G; Schunkert H
    Z Kardiol; 2001 Sep; 90(9):646-54. PubMed ID: 11677801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive cardiac rehabilitation improves the control of dyslipidemia in secondary prevention.
    Vergès BL; Patois-Vergès B; Cohen M; Casillas JM
    J Cardiopulm Rehabil; 1998; 18(6):408-15. PubMed ID: 9857272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P; Kapoor A; Sinha A; Agarwal SK; Pande S; Khanna R; Srivastava N; Kumar S; Garg N; Tewari S; Goel P
    Indian J Med Res; 2017 Dec; 146(6):722-729. PubMed ID: 29664030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality.
    Alkofide H; Alshuhayb R; Alhazmi N; Almofada R; Bin Hazzaa A; Alsharif A; Abouzaid H
    Cureus; 2022 Apr; 14(4):e24000. PubMed ID: 35547465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting.
    Völler H; Gitt A; Jannowitz C; Karoff M; Karmann B; Pittrow D; Reibis R; Hildemann S
    Eur J Prev Cardiol; 2014 Sep; 21(9):1125-33. PubMed ID: 23508927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.